Healthcare Roundup – FDA getting cold feet on EUA nod for COVID-19 vaccines, AstraZeneca COVID-19 deal allows 20% gross profit Life Science
Technology Roundup – Judge won’t let U.S. block Tencent’s WeChat during appeal process, Facebook tries to shut down NYU political ad study Technology
Technology Roundup – IBM, Alibaba, and Huawei sign on to help Saudi Arabia’s AI push; IBM, Pfizer design AI model that can predict Alzheimer’s in seemingly healthy patients Technology
Healthcare Roundup – FDA OKs Gilead’s remdesivir, Moderna completes enrollment for Phase 3 study of Covid-19 vaccine Life Science
Healthcare Roundup – J&J’s daratumumab extends survival in first-line multiple myeloma, Death reported in Brazil study of AstraZeneca COVID-19 vaccine Life Science
Technology Roundup – Chinese tech firms flag concerns about Nvidia’s Arm deal, Jack Ma’s Ant Group gets Chinese approval for Shanghai arm of $35B IPO Technology
Healthcare Roundup – CytoDyn study of leronlimab for COVID-19 passes first interim tollgate, Novavax to present COVID-19 vaccine data Life Science
Technology Roundup – Google shares rise amid landmark U.S. antitrust suit, Adobe launches Illustrator for iPad Technology
Healthcare Roundup – CVS looks to hire another 15,000 employees, Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets Life Science
Technology Roundup – Intel sells storage unit to SK Hynix in $9B deal, IBM slips after third consecutive revenue decline Technology
Healthcare Roundup – Sinovac’s COVID-19 vaccine offered by Chinese city for emergency use, CytoDyn to discuss DSMC’s review of interim analysis in COVID-19 Life Science
Technology Roundup – Ant Group’s IPO valuation increases again to $280B, China set to approve its own tech protection law Technology
Healthcare Roundup – Remdesivir has little effect on mortality, Gilead Science lands WHO distinction for remdesivir Life Science
Technology Roundup – FCC Chairman Pai says he’ll revisit social-media law, Big Tech sentiment gets shaky Technology
